CORVITA 150- iron, folic acid, ascorbic acid, pyridoxine hydrochloride, cyanocobalamin and zinc tablet
TRIGEN Laboratories, Inc.
----------
Iron is an essential component in the formation of hemoglobin. Adequate amounts of iron are necessary for effective erythropoiesis. Iron also serves as a cofactor of several essential enzymes, including cytochromes that are involved in electron transport.
Folic acid is required for nucleoprotein synthesis and the maintenance of normal erythropoiesis. Folic acid is converted in the liver and plasma to its metabolically active form, tetrahydrofolic acid, by dihydrofolate reductase.
Vitamin B12 is required for the maintenance of normal erythropoiesis, nucleoprotein and myelin synthesis, cell reproduction and normal growth. Intrinsic factor, a glycoprotein secreted by the gastric mucosa, is required for active absorption of Vitamin B12 from the gastrointestinal tract.
CORVITATM 150 is indicated for the prevention and treatment of iron deficiency anemia and / or nutritional megaloblastic anemias.
CORVITATM 150 is is contraindicated in patients with a known hypersensitivity to any of the components of this product. Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately. |
Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with CORVITA TM 150 Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.
Supplement Facts
Servings per Carton: 100 |
||
Serving Size: 1 Tablet Each Tablet contains | %DV for Adults Only | |
Iron (ferronyl, micronised)..... | 150 mg | .....833% |
Folic Acid.............. | 1.25 mg | ......313% |
Vitamin C (ascorbic acid)....... | 120 mg | ........200% |
Vitamin B6 (pyridoxine HCl)...... | 10 mg | ......2500% |
Vitamin B12 (cyanocobalamin)...... | 15 mcg | ......200% |
Zinc (citrate)...... | 25 mg | .....167% |
Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. There are no implied or explicit claims on therapeutic equivalences.
CORVITATM 150 are red, oval bisected tablets embossed “VP031” and are supplied in unit dose pack of 100 (10 blister cards of 10 tablets each).
PRODUCT CODE 13811-066-10.
Store at 20°-25°C (68°-77°F), excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.
KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.
CORVITA 150
iron, folic acid, ascorbic acid, pyridoxine hydrochloride, cyanocobalamin and citrate tablet |
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
Labeler - TRIGEN Laboratories, Inc. (830479668) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
VIVA PHARMACEUTICAL INC. | 253288898 | manufacture(13811-066) |